XTL BIOPHARMACEUTICALS LTD. Current Assets
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Current Assets of $1.34 million as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2025-04-30
- 2024-12-31: Current Assets $1.34M.
- 2023-12-31: Current Assets $2.05M.
- 2022-12-31: Current Assets $3.81M.
- 2022-06-30: Current Assets $5.38M.
| Period end | Current Assets |
|---|---|
| 2024-12-31 | $1.34M 20-F · filed 2025-04-30 |
| 2023-12-31 | $2.05M 20-F · filed 2025-04-30 |
| 2022-12-31 | $3.81M 20-F · filed 2023-03-22 |
| 2022-06-30 | $5.38M 6-K · filed 2022-08-24 |
| 2021-12-31 | $6.24M 20-F · filed 2023-03-22 |
| 2021-06-30 | $6.57M 6-K · filed 2021-08-24 |
| 2020-12-31 | $6.12M 20-F · filed 2022-03-30 |
| 2019-12-31 | $6.83M 20-F/A · filed 2021-05-19 |
| 2019-01-01 | $8.20M 20-F/A · filed 2021-05-19 |
| 2018-12-31 | $8.20M 20-F · filed 2020-03-12 |
| 2017-12-31 | $6.21M 20-F · filed 2019-03-11 |
| 2016-12-31 | $2.75M 20-F · filed 2018-03-15 |